Literature DB >> 1672025

Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS.

P Portegies, P R Algra, C E Hollak, J M Prins, P Reiss, J Valk, J M Lange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1672025     DOI： 10.1016/0140-6736(91)92504-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

Review 2.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

4.  Progressive multifocal leukoencephalopathy in patients with AIDS: detection of JC virus DNA in CSF and brain.

Authors:  C J Perrons; R J Chinn; J D Fox; S B Lucas; M J Harrison; R F Miller
Journal:  Genitourin Med       Date:  1995-02

5.  Activities of various compounds against murine and primate polyomaviruses.

Authors:  G Andrei; R Snoeck; M Vandeputte; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 6.  [Progressive multifocal leukoencephalopathy].

Authors:  J C Wasmuth; A Wasmuth-Pietzuch; U Spengler; J K Rockstroh
Journal:  Med Klin (Munich)       Date:  1999-05-15

7.  Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside.

Authors:  A J Aksamit
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

8.  Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.

Authors:  W Royal; B Dupont; D McGuire; L Chang; K Goodkin; T Ernst; M J Post; D Fish; G Pailloux; H Poncelet; M Concha; L Apuzzo; E Singer
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

9.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

Review 10.  Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature.

Authors:  R W von Einsiedel; T D Fife; A J Aksamit; M E Cornford; D L Secor; U Tomiyasu; H H Itabashi; H V Vinters
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.